Titan Pharmaceuticals, Inc.

Navigate Titan Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Who We Are
    • IP Portfolio
    • Management Team
    • Board of Directors
    • Careers
  • Technology
  • Pipeline
    • Kappa Opioid Receptor Agonist
    • Nalmefene Implant
  • News
    • Overview
    • Press Releases
    • Events
    • Presentations
    • In the News
    • Publications
    • Posters
    • Media Resources
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • Search
  • Twitter

Press Releases

  • Home
  • News
  • Press Releases
News

Navigate News

  • Overview
  • Press Releases
  • Events
  • Presentations
  • In the News
  • Publications
  • Posters
  • Media Resources

Press Releases

  • All News
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009

Titan Pharmaceuticals to Present at LD Micro Conference

December 1, 2014

Titan Pharmaceuticals Announces Completion of Enrollment in Phase 3 Study of Probuphine for Opioid Dependence

November 20, 2014

Titan Pharmaceuticals Announces Third Quarter 2014 Financial Results

November 13, 2014

Titan Pharmaceuticals Appoints Two New Board Members

November 11, 2014

Titan Pharmaceuticals Schedules Conference Call to Review Third Quarter 2014 Financial Results

November 7, 2014

Titan Pharmaceuticals Announces Pricing of Public Offering

October 3, 2014

Titan Pharmaceuticals Announces Enrollment Reaches Halfway Mark in Phase 3 Study of Probuphine for Opioid Dependence

September 23, 2014

Titan Pharmaceuticals to Present at Rodman & Renshaw 16th Annual Global Investment Conference

September 3, 2014

Titan Pharmaceuticals Announces Second Quarter 2014 Financial Results

August 13, 2014

Titan Pharmaceuticals Schedules Conference Call to Review Second Quarter 2014 Financial Results

August 7, 2014

  • 1
  • 2
  • Next »
© 2023 Titan Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Titan FCOI Policy Disclaimer Sitemap Twitter